BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 7690921)

  • 21. The natural history of theca lutein cysts.
    Montz FJ; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1988 Aug; 72(2):247-51. PubMed ID: 2455880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of partial molar pregnancy.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molar pregnancy (primary or recurrent?)].
    Ayala A; Aizpuru E; Tovar JM
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 27. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
    Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
    Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Watch out for the false low levels of hCG!].
    Flam F; Hansson LO
    Lakartidningen; 1997 Apr; 94(17):1614-5. PubMed ID: 9182163
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete molar pregnancy with very low serum hCG.
    Banerjee AK; Gyesi-Appiah A; McCullough WL
    J Obstet Gynaecol; 2009 Apr; 29(3):268-9. PubMed ID: 19358054
    [No Abstract]   [Full Text] [Related]  

  • 35. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.